The 12 closest competitors and alternatives to Embold Therapeutics, Inc. among biotechnology companies — ranked by similarity to what Embold Therapeutics, Inc. actually does, not by market-cap band.
Subscribe to see Embold Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Embold Therapeutics, Inc. is a life-sciences company located in Redwood City, California.
Embold Therapeutics, Inc. is a biotechnology company headquartered in United States. It has raised at least $4.8M across the 2 funding rounds on record. Its most recent funding round, Series B, raised $2.3M in July 2026. Xcout tracks 6 named people at Embold Therapeutics, Inc., including Gjalt Huisman (CEO).
At least $4.8M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $2.3M | 4 named | |
| SEC Form D filing | $2.5M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Ranked by semantic similarity — how close each company is to Embold Therapeutics, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Life Sciences
Rubedo Life Sciences is a clinical-stage biopharmaceutical company headquartered in Sunnyvale and Mountain View, California, developing a broad portfolio of innovative therapies.
Similar biotechnology company
Trellis Bioscience, Inc. is a clinical-stage biotechnology company located in Redwood City, California, focused on developing antibody-based therapeutics.
Biotech
Encoded Therapeutics is a biotechnology company headquartered in South San Francisco, California, dedicated to developing next-generation genetic medicines designed to address the root causes of genetic diseases.
Biotech
Bolt Biotherapeutics, Inc. is a biotechnology company currently conducting clinical trials, focused on developing innovative immuno-oncology therapies. Its mission is to create agents that equip the body's immune system to identify and eliminate cancerous cells. A key therapeutic in its pipeline is BDC-1001, an investigational treatment targeting the human epidermal growth factor receptor 2 (HER2). This compound is presently undergoing Phase I/II clinical evaluation for patients with HER2-positive solid tumors, including those exhibiting low HER2 expression. Beyond BDC-1001, the company is advancing several other programs: BDC-2034, which targets carcinoembryonic antigen for various indications such as colorectal, non-small cell lung, pancreatic, and breast cancers; and BDC-3042, a Dectin-2 agonist antibody designed to reprogram crucial immune cells within the tumor microenvironment by interacting with macrophage cell-surface receptors. Bolt is also pursuing a programmed cell death-ligand 1 (PD-L1) initiative aimed at addressing tumors that prove resistant to existing immune checkpoint blockades. Incorporated in 2015 under its previous name, Bolt Therapeutics, Inc., before officially becoming Bolt Biotherapeutics, Inc. in July of the same year, the company maintains its corporate headquarters in Redwood City, California.
Similar biotechnology company
Bolden Therapeutics, Inc. is a privately held biotechnology company founded in 2019 and headquartered in Providence, Rhode Island, with corporate office space in Boston, Massachusetts. The company is dedicated to developing first-in-class therapeutics.
Biotech
Coherus BioSciences, Inc. is a biopharmaceutical company headquartered in Redwood City, California, focused on oncology and developing innovative therapeutics.
Similar biotechnology company
Halda Therapeutics is a life sciences and drug discovery company based in New Haven, Connecticut, focused on developing targeted therapeutics.
Similar biotechnology company
Revolution Medicines is a biotechnology research company headquartered in Redwood City, California. Its mission is to revolutionize treatment for patients with RAS-addicted cancers through targeted medicines, translating frontier oncology targets.
Similar biotechnology company
Mosanna Therapeutics is a biopharmaceutical company with offices in Redwood City, California and Basel, Switzerland. The company focuses on developing novel treatments for metabolic and cardiovascular diseases. It launched with $80 million in funding to advance its clinical pipeline.
Similar biotechnology company
Tempero Bio, Inc. is a clinical-stage biopharmaceutical holding company established in 2020 and headquartered in Oakland, California. The company focuses on developing transformative therapeutics and advancing its drug pipeline through clinical trials.
Similar biotechnology company
Notable Labs, Inc. is a clinical-stage therapeutic platform company headquartered in Foster City, California. The company focuses on drug pipelines, patents, and clinical trials, and operates as a public company traded on NASDAQ under the ticker NTBL.
Similar biotechnology company
Kriya Therapeutics, Inc. is a fully integrated biopharmaceutical company with operational footprints in Redwood City, California, and Research Triangle Park, North Carolina. The company develops novel gene therapies to address diverse diseases.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Embold Therapeutics, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →